Literature DB >> 26342226

Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis.

Lisa M Rice1, Giuseppina Stifano1, Jessica Ziemek1, Robert Lafyatis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26342226      PMCID： PMC4939726          DOI： 10.1093/rheumatology/kev335

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

2.  Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets.

Authors:  Matthew B Greenblatt; Jennifer L Sargent; Giuseppina Farina; Kelly Tsang; Robert Lafyatis; Laurie H Glimcher; Michael L Whitfield; Antonios O Aliprantis
Journal:  Am J Pathol       Date:  2012-01-11       Impact factor: 4.307

3.  A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.

Authors:  G Farina; D Lafyatis; R Lemaire; R Lafyatis
Journal:  Arthritis Rheum       Date:  2010-02

4.  Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.

Authors:  P J Clements; E L Hurwitz; W K Wong; J R Seibold; M Mayes; B White; F Wigley; M Weisman; W Barr; L Moreland; T A Medsger; V D Steen; R W Martin; D Collier; A Weinstein; E Lally; J Varga; S R Weiner; B Andrews; M Abeles; D E Furst
Journal:  Arthritis Rheum       Date:  2000-11

Review 5.  Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Authors:  John Varga; David Abraham
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

6.  Improvement in skin thickening in systemic sclerosis associated with improved survival.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  2001-12

7.  Systemic and cell type-specific gene expression patterns in scleroderma skin.

Authors:  Michael L Whitfield; Deborah R Finlay; John Isaac Murray; Olga G Troyanskaya; Jen-Tsan Chi; Alexander Pergamenschikov; Timothy H McCalmont; Patrick O Brown; David Botstein; M Kari Connolly
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

8.  Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis.

Authors:  Giuseppina Stifano; Alsya J Affandi; Allison L Mathes; Lisa M Rice; Sashidhar Nakerakanti; Banafsheh Nazari; Jungeun Lee; Romy B Christmann; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2014-07-01       Impact factor: 5.156
  8 in total
  10 in total

1.  Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82.

Authors:  Robert Lafyatis; Julio C Mantero; Jessica Gordon; Nina Kishore; Mary Carns; Howard Dittrich; Robert Spiera; Robert W Simms; John Varga
Journal:  J Invest Dermatol       Date:  2017-08-12       Impact factor: 8.551

2.  Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.

Authors:  Shane Lofgren; Monique Hinchcliff; Mary Carns; Tammara Wood; Kathleen Aren; Esperanza Arroyo; Peggie Cheung; Alex Kuo; Antonia Valenzuela; Anna Haemel; Paul J Wolters; Jessica Gordon; Robert Spiera; Shervin Assassi; Francesco Boin; Lorinda Chung; David Fiorentino; Paul J Utz; Michael L Whitfield; Purvesh Khatri
Journal:  JCI Insight       Date:  2016-12-22

3.  14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma.

Authors:  Sandra Cascio; Thomas A Medsger; William F Hawse; Simon C Watkins; Christine Milcarek; Larry W Moreland; Robert A Lafyatis; Patrizia Fuschiotti
Journal:  J Allergy Clin Immunol       Date:  2017-11-15       Impact factor: 10.793

Review 4.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

Review 5.  Emerging Roles of Matricellular Proteins in Systemic Sclerosis.

Authors:  Daniel Feng; Casimiro Gerarduzzi
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

6.  Differential DNA Methylation Landscape in Skin Fibroblasts from African Americans with Systemic Sclerosis.

Authors:  DeAnna Baker Frost; Willian da Silveira; E Starr Hazard; Ilia Atanelishvili; Robert C Wilson; Jonathan Flume; Kayleigh L Day; James C Oates; Galina S Bogatkevich; Carol Feghali-Bostwick; Gary Hardiman; Paula S Ramos
Journal:  Genes (Basel)       Date:  2021-01-20       Impact factor: 4.096

Review 7.  Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

Authors:  Theodoros-Ioannis Papadimitriou; Arjan van Caam; Peter M van der Kraan; Rogier M Thurlings
Journal:  Biomedicines       Date:  2022-01-29

Review 8.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

9.  Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.

Authors:  Emma C Derrett-Smith; Viktor Martyanov; Cecilia B Chighizola; Pia Moinzadeh; Corrado Campochiaro; Korsa Khan; Tammara A Wood; Pier Luigi Meroni; David J Abraham; Voon H Ong; Robert Lafyatis; Michael L Whitfield; Christopher P Denton
Journal:  Arthritis Res Ther       Date:  2017-07-04       Impact factor: 5.156

10.  Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis.

Authors:  Benjamin Korman; Roberta Goncalves Marangoni; Gabriel Lord; Jerrold Olefsky; Warren Tourtellotte; John Varga
Journal:  Arthritis Res Ther       Date:  2018-07-11       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.